PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-70.35%
Negative net income growth while META stands at 10.17%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-0.19%
Negative yoy D&A while META is 11.33%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-434.82%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
2.19%
Less SBC growth vs. META's 16.57%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-47.40%
Both reduce yoy usage, with META at -271.20%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-248.80%
Both yoy AR lines negative, with META at -147.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-35.14%
Negative yoy inventory while META is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
68.98%
Lower AP growth vs. META's 144.49%, indicating prompt payments. David Dodd would confirm no lost opportunity in interest-free credit if expansions are underfunded.
163.79%
Growth well above META's 93.48%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
10837.11%
Well above META's 175.76%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-2.87%
Negative yoy CFO while META is 6.39%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
18.53%
Some CapEx rise while META is negative at -27.80%. John Neff would see competitor possibly building capacity while we hold back expansions.
-232.69%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-157.63%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
176.24%
At 75-90% of META's 198.35%. Bill Ackman would push for additional sales if those assets are non-strategic or have peaked in value.
No Data
No Data available this quarter, please select a different quarter.
-59.80%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.